Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-22-003474
Filing Date
2022-05-10
Accepted
2022-05-10 06:05:10
Documents
2
Period of Report
2022-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_051022.htm 6-K 7529
2 EXHIBIT 99.1 exh_991.htm EX-99.1 7710
  Complete submission text file 0001171843-22-003474.txt   16209
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39179 | Film No.: 22907206
SIC: 2834 Pharmaceutical Preparations